Total (n = 61) | Non-frail (n = 35) | Frail (n = 26) | p | |
---|---|---|---|---|
Mean ± SD or n (%) | ||||
Age (years) | 60.5 ± 11.5 | 57.3 ± 11.4 | 64.9 ± 10.3 | 0.009* |
Female | 25 (41.0%) | 10 (28.6%) | 15 (57.7%) | 0.02* |
Black phenotype | 28 (45.9%) | 13 (37.1%) | 11 (42.3%) | 0.11 |
Body mass index (kg/m 2) | 25.9 ± 5.0 | 26.2 ± 4.0 | 28.0 ± 5.5 | 0.16 |
Smoking status | 9 (14.8%) | 5 (14.3%) | 4 (15.4%) | 0.90 |
Chronic kidney disease stages | 0.15 | |||
3 | 24 (39.3%) | 17 (48.6%) | 7 (26.9%) | |
4 | 25 (42.6%) | 12 (34.3%) | 13 (50.0%) | |
5 | 12 (19.7%) | 6 (17.1%) | 6 (23.1%) | |
Etiology of chronic kidney disease | 0.56 | |||
Arterial hypertension | 18 (29.5%) | 11 (31.4%) | 7 (26.9%) | |
Diabetes mellitus | 11 (18.0%) | 4 (11.4%) | 7 (26.9%) | |
Glomerulonephritis | 9 (14.8%) | 7 (20.0%) | 2 (7.7%) | |
Unknown | 8 (13.1%) | 4 (11.4%) | 4 (15.4%) | |
Undetermined or other | 15 (24.6%) | 9 (25.7%) | 6 (23.1%) | |
Comorbidities | 0.10 | |||
Arterial hypertension | 23 (56.1%) | 14 (40.0%) | 9 (34.6%) | |
Diabetes mellitus | 4 (9.8%) | 3 (8.6%) | 1 (2.6%) | |
Other | 25 (41.0%) | 11 (31.5%) | 14 (53.9%) | |
None | 9 (22.0%) | 7 (20.0%) | 2 (7.7%) | |
Creatinine (mg/dL) | 2.7 ± 1.3 | 2.7 ± 1.5 | 2.7 ± 1.0 | 0.89 |
Glomerular filtration rate (mL/min/ 1.73 m 2) | 26.8 ± 12.9 | 28.6 ± 13.1 | 24.3 ± 12.5 | 0.19 |
SF-36 domains | ||||
Physical functioning | 67.2 ± 25.3 | 84 ± 15.3 | 46 ± 19 | 0.0001* |
Role physical | 65.9 ± 38.7 | 75 ± 35.3 | 53.8 ± 40.4 | 0.03* |
Bodily pain | 68.8 ± 31.7 | 76.5 ± 26.7 | 58.4 ± 35.3 | 0.03* |
General health | 56.4 ± 25.2 | 62 ± 23.8 | 48.9 ± 25.6 | 0.04* |
Vitality | 69.5 ± 23.3 | 77.4 ± 21.6 | 58.8 ± 21.5 | 0.002* |
Social functioning | 85.4 ± 25.7 | 84.9 ± 28.4 | 86 ± 22.1 | 0.87 |
Role emotional | 74.5 ± 37.2 | 76.1 ± 36.7 | 72.3 ± 38.5 | 0.69 |
Mental health | 76.0 ± 22.3 | 80.8 ± 21.3 | 69.5 ± 22.5 | 0.05* |